Uso de tratamientos contra diana en Oncología y su impacto en el diseño de estudios clínicos: los receptores del factor de crecimiento epidérmico 1 y 2 como paradigma / The use of targeted therapies in Oncology and their impact in the design of clinical trials: Epidermal growth factor receptors 1 and 2 as a paradigm
Med. clín (Ed. impr.)
; 141(4): 176-180, ago. 2013.
Article
in Es
| IBECS
| ID: ibc-114422
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
No disponible
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Epidermal Growth Factor
/
Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
Es
Journal:
Med. clín (Ed. impr.)
Year:
2013
Document type:
Article